Fundraising FoxVeltro Argento
Venture capitalStamford · 1 people tracked
Find your way into Veltro Argento
Sign up to see every warm intro you have to Veltro Argento
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Veltro Argento team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Fund manager profile
Veltro Argento is a venture fund manager based in Stamford. SEC filings show 1 venture fund on record, most recently Veltro Argento LP filed June 2020.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
Team · 1 people
from public directoriesWhat they invest in
from 3 of 3 portfolio companiesBiotech ×3Healthtech ×1Medical Devices ×1
HQs:United States×3
Investments · 3 tracked
founders shown can be your intro pathBy year:2021 · 12020 · 12018 · 13 dated
Invivyd develops monoclonal antibody therapies to prevent and treat serious viral infections, beginning with COVID-19 and expanding to respiratory syncytial virus and measles.
BiotechWaltham, US
Tillman U. Gerngross(Executive Officer, Director)Lynn Connolly(Executive Officer)Eric Kimble(Executive Officer)inHalley Gilbert(Executive Officer)Rebecca Dabora(Executive Officer)inEllie Hershberger(Executive Officer)
Board seatMarc Elia· per SEC Form D · $23.7M raise · filed Nov 2022
Co-investorsGV (Google Ventures)Fidelity InvestmentsForesite CapitalMithril Capital ManagementOmega FundsOrbiMed+3 more
Fractyl develops therapies for obesity and type 2 diabetes, focusing on non-drug-based approaches rooted in understanding metabolic disease mechanisms.
BiotechHealthtechMedical DevicesLexington, US
Jay Caplan(Founder)inHarith Rajagopalan(Founder)inLISA DAVIDSON(Executive Officer)inDiane Marcou(Executive Officer)in
BoardAllan Will(Director)inNimesh Shah(Director)in
Board seatMarc Elia· per SEC Form D · $100M raise · filed Jun 2021
Co-investorsBessemer Venture PartnersCatalio Capital Management, LPEmergent Medical Partners, LLPGeneral CatalystMithril Capital ManagementDomain Associates+1 more
.png)
BiotechWatertown, US
Robert S. Langer, Sc.D.(Director)Armon Sharei, Ph.D.(Executive Officer, Director)Armon Sharei(Executive Officer, Director)Amy W. Schulman(Executive Officer, Director)Kris Elverum(Executive Officer)Howard Bernstein(Executive Officer)
Board seatMarc Elia· per SEC Form D · $70.2M raise · filed Jun 2020
Co-investorsAlumni Ventures+ND CapitalGV (Google Ventures)Illumina VenturesInvusJDRF T1D Fund+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 2
2 IPOsAdagio TherapeuticsNASDAQ: IVVDFractylNASDAQ: GUTS
Frequently asked questions
- Where is Veltro Argento located?
- Veltro Argento is headquartered in Stamford, US.